Supreme Court Decision Impacts FDA. The recent Supreme Court ruling to overturn the Chevron doctrine could significantly affect FDA regulations, including lab-developed tests (LDTs). The 6-3 decision means courts no longer defer to federal agencies on ambiguous statutes, with broad implications for all agencies. Jeff Gibbs from Hyman, Phelps & McNamara highlighted potential unforeseen effects, especially for the medical device industry. Despite this, the FDA remains confident in its legal foundations. Former FDA Commissioner Scott Gottlieb noted immediate impacts on LDT regulations, which recently shifted to stricter oversight due to growing risks associated with these tests. Read below to learn more about the implications of this change. https://lnkd.in/gDfXywXJ #MetricBio #SupremeCourt #FDA #ChevronDoctrine #LDTs #Regulation #MedTech
About us
Utilizing our expertise to provide recruitment solutions to some of the worlds most cutting-edge companies in MedTech and Life Science. Our world-leading team of expert’s passion lies in deliver cutting edge talent solutions to visionary clients, positively impacting human health within a variety of specialisms including: - Biotech - CDMO - CRO - MedTech New York | London | Florida | Nottingham
- Website
-
http://www.metric-search.com
External link for Metric Bio
- Industry
- Staffing and Recruiting
- Company size
- 51-200 employees
- Headquarters
- New York
- Type
- Privately Held
- Specialties
- Biotech , Genomics, Lab Automation, Cell & Gene Therapy, Cellular Agriculture, CDMO, Biologics, Drug Products, API, CRO, Pre-Clinical, Clinical, E-Clinical, Clinical Trial Supply, Drug Discovery, Digital Health, HealthTech, Artificial Intelligence, SaaS, Telemedicine, MedTech, Neurotech, FemTech, Cardiovascular, Medical Imagine & AI, Surgical Robotics, Orthopaedic and Spine, Pharma, and Molecular Diagnostics
Locations
-
Primary
New York, US
-
Fort Lauderdale, US
-
London, GB
-
Nottingham, GB
Employees at Metric Bio
Updates
-
Last week marked a pivotal milestone for Metric as we secured multi-million-pound investment from BGF. Following 5 years' of outperforming the market, this partnership will help further supercharge our growth, and is the culmination of everything we've been working towards with Metric 2.0. The deal also saw the introduction of Andy McRae as our new Non-Exec Chairman. Andy brings with him a wealth of experience and is a valuable addition to our team. In true Metric fashion, we're already looking ahead to what's next. If you want to be a part of something truly market-leading, drop us a message to learn more. https://lnkd.in/edprKiSa #metricbio #bgf #recruitment #investment #privateequity
Metric Search secures multi-million BGF investment to drive US growth - BGF
https://www.bgf.co.uk
-
Our team at Metric Bio ensures transparent communication, using their specialised industry knowledge, to help our partners get the most out of their experience with us. Why not see for yourself? Get in touch with one of our world-class talent acquisition specialists today. Visit our jobs page to see where your next career change could take you and read below about some of our current available roles. https://lnkd.in/eFaZ2U3D #MetricBio #CurrentRoles #Worldwide
-
-
At Metric Bio, we have a commitment to the continuous development of long-lasting, meaningful relationships through trust, honest communication and shared goals to ensure a sustainable and successful future for all our candidates and clients. Alex Alves-Khan is a testament to this value at Metric Bio and we’re not the only ones that think so. Why not read below about Kyle J. Lauterbach, MBA, PMP’s experience with Alex Alves-Khan in securing him a position at Scorpius BioManufacturing, Inc., and visit Alex's webpage to read more about his track record. https://lnkd.in/dzBW-RXn #MetricBio #Testimony #ScorpiusBioManufacturing
-
James Barraclough is a highly experienced Senior Group Business Manager at Metric Bio, providing prime talent acquisition solutions for the global medical device market. James Barraclough prides himself on his knowledge of the industry, even hosting his own podcast, "The MedTech Pulse," where he discusses all things related to medical technology. The podcast is available to listen to now on Spotify - https://lnkd.in/gTMrWhaT Why not watch the snippet below of James Barraclough’s interview with Daniel Perez about Hinge Health and their digital clinic for joint and muscle care? And visit James Barraclough’s webpage to learn more about his amazing track record. https://lnkd.in/gvUSiq25 #MetricBio #Testimony #Podcast #Medtech
-
Eli Lilly and Company is acquiring Morphic Therapeutic a biopharmaceutical leader in oral integrin therapies for chronic diseases. Daniel Skovronsky, Lilly’s Chief Scientific Officer, stated, "Oral therapies like MORF-057 could revolutionize early intervention and combination treatments for diseases such as ulcerative colitis. We eagerly welcome the Morphic team to Lilly." Key Details: - Lilly will acquire all Morphic shares for $57 each, totalling approximately $3.2 billion. - The transaction, expected to close in Q3 2024, represents a 79% premium to Morphic's July 5, 2024 closing price. Read below to learn more about this deal. https://lnkd.in/dqjx6JTb #MetricBio #Lilly #MorphicHolding #Biopharma #HealthcareInnovation
Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease | Eli Lilly and Company
investor.lilly.com
-
Charles River Laboratories and AAVantgarde Bio have entered a CDMO agreement to produce GMP plasmid DNA. AAVantgarde Bio, with its innovative AAV vector platforms for large gene delivery, will use Charles River Laboratories' expertise to advance treatments for inherited retinal diseases, beginning with Stargardt's disease. Stargardt's, the most common inherited macular dystrophy, affects 1 in 6,500 people and currently has no therapies. This partnership leverages Charles River Laboratories’ GMP plasmid DNA CDMO center in Keele, UK, to support AAVantgarde Bio's Stargardt's disease program. Read more below about this agreement. https://lnkd.in/eV23ymd9 #CharlesRiver #AAVantgarde #GeneTherapy #CDMO #HealthcareInnovation
Charles River to Perform Plasmid Manufacturing for AAVantgarde
lelezard.com
-
Check out our most recently published job roles to see where your next career change could take you and discover more about our talented team at Metric Bio by visiting our website. https://lnkd.in/enq8Qiwc #MetricBio #Recruitment #Onsite #TalentAcquisition
-
-
Happy 4th of July from Metric Bio! We hope everyone enjoys a fantastic day filled with fun, relaxation, and great company. Whether you're watching fireworks, having a barbecue, or just kicking back, enjoy the holiday! From all of us at Metric Bio, have a safe and happy Independence Day! #FourthOfJuly #Metric #Celebrate #Recruitmen
-
-
John-Joe Walker’s promotion to Chief Commercial Officer is a testament to his work and dedication to Metric Bio as a world-leading MedTech search partner. Read about Anthony Arnold’s experience with John-Joe Walker, and visit John-Joe’s webpage to learn more about his incredible track record. https://lnkd.in/efmVNGaQ #MetricBio #Recruitment #CCO
-